Endocrinology, Diabetes & Metabolism·19 SepLiraglutide in Adults With Obesity: A Multicentre, Single-Arm, Post-Marketing Surveillance Study in TaiwanNon-randomised trial in 259 peopleLiraglutidePaper
Obesity Research & Clinical Practice·15 SepA multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in TaiwanTrial in 41 peopleGLP-1 receptor agonistsPaper
The Lancet Diabetes & Endocrinology·11 AugEfficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trialRandomised trial in 242 peopleSemaglutidePaper
ADA Scientific Sessions 2026 Abstract·5 JunCombination of Tirzepatide with CBL-514 an Adipocyte-Apoptosis Agent Improves Weight Loss Durability and Adipose Tissue Remodeling in Diet-Induced Obese RatsExperiments in animalsInterventionsPaper